M&A Deal Summary

Icagen Acquires Sanofi s Oro Valley

On June 27, 2016, Icagen acquired life science company Sanofi s Oro Valley

Acquisition Highlights
  • This is Icagen’s 1st transaction in the Life Science sector.
  • This is Icagen’s 1st transaction in the United States.
  • This is Icagen’s 1st transaction in Arizona.

M&A Deal Summary
Date 2016-06-27
Target Sanofi s Oro Valley
Sector Life Science
Buyer(s) Icagen
Deal Type Add-on Acquisition

Target

Sanofi s Oro Valley

Oro Valley, Arizona, United States
Sanofi's Oro Valley is an opeator of ultra high-throughput biology, screening and chemistry capabilities and research facility in Oro Valley, Arizona.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Icagen

Durham, North Carolina, United States
Category Company
Founded 1992
Sector Life Science
Employees38
DESCRIPTION

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-11 Icagen - North Carolina Operations

North Carolina, United States

Icagen, Inc. - North Carolina Operations includes partnered programs, proprietary ion channel screening and assay platforms, x-ray fluorescence capabilities, custom screening technologies and novel unpartnered preclinical-stage molecules.

Sell $15M
Mergr

Product

Company

Legal